Journal of Molecular Biology · 2017 · 63 citations · 42 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryLead OptimizationHit-to-lead OptimizationPharmacokinetic OptimizationPotency OptimizationReceptor Tyrosine Kinase SignalingTyrosine Kinase InhibitorsKinase Inhibitor Library DesignKinase InhibitorsKinase Signaling InhibitorsSmall Molecule Tyrosine Kinase InhibitorsTarget OptimizationTargeted Kinase InhibitionTyrosine Kinase Inhibitor Pharmacokinetics
42
Features and development of <i>Coot</i>
Paul Emsley, Bernhard Lohkamp, W. G. Scott et al. · Acta Crystallographica Section D Biological Crystallography · 2010 · 29.6K citations · Full text
Overview of the<i>CCP</i>4 suite and current developments
Martyn Winn, Charles Ballard, Kevin Cowtan et al. · Acta Crystallographica Section D Biological Crystallography · 2011 · 12.6K citations · Full text
A Landscape of Pharmacogenomic Interactions in Cancer
Francesco Iorio, Theo Knijnenburg, Daniël J. Vis et al. · Cell · 2016 · 2.3K citations · Full text
Medicine, Cancer Biology, Oncology +17
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
John C. Byrd, Richard R. Furman, Steven Coutré et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text
Medicine, Hematology, Oncology +12
A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)
Edgar R. Wood, Anne T. Truesdale, Octerloney B. McDonald et al. · Cancer Research · 2004 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +14